Sheena Sharma1, Michelle R Denburg2,3, Susan L Furth2,3. 1. Division of Nephrology, Phoenix Children's Hospital, 1919 E Thomas Road, Building E, Suite 200, Phoenix, AZ, 85016, USA. ssharma@phoenixchildrens.com. 2. Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 3. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Abstract
BACKGROUND: Children with chronic kidney disease (CKD) have a high prevalence of cardiovascular disease (CVD) risk factors which may contribute to the development of cardiovascular events in adulthood. Among adults with CKD, cystatin C-based estimates of glomerular filtration rate (eGFR) demonstrate a stronger predictive value for cardiovascular events than creatinine-based eGFR. The PDAY (Pathobiological Determinants of Atherosclerosis in Youth) risk score is a validated tool used to estimate the probability of advanced coronary atherosclerotic lesions in young adults. OBJECTIVE: To assess the association between cystatin C-based versus creatinine-based eGFR (eGFR cystatin C and eGFR creatinine, respectively) and cardiovascular risk using a modified PDAY risk score as a proxy for CVD in children and young adults. METHODS: We performed a cross-sectional study of 71 participants with CKD [median age 15.5 years; inter-quartile range (IQR) 13, 17], and 33 healthy controls (median age 15.1 years; IQR 13, 17). eGFR was calculated using age-appropriate creatinine- and cystatin C-based formulas. Median eGFR creatinine and eGFR cystatin C for CKD participants were 50 (IQR 30, 75) and 53 (32, 74) mL/min/1.73 m2, respectively. For the healthy controls, median eGFR creatinine and eGFR cystatin were 112 (IQR 85, 128) and 106 mL/min/1.73m2 (95, 123) mL/min/1.73 m2, respectively. A modified PDAY risk score was calculated based on sex, age, serum lipoprotein concentrations, obesity, smoking status, hypertension, and hyperglycemia. RESULTS: Modified PDAY scores ranged from -2 to 20. The Spearman's correlations of eGFR creatinine and eGFR cystatin C with coronary artery PDAY scores were -0.23 (p = 0.02) and -0.28 (p = 0.004), respectively. Ordinal logistic regression also showed a similar association of higher eGFR creatinine and higher eGFR cystatin C with lower PDAY scores. When stratified by age <18 or ≥18 years, the correlations of eGFR creatinine and eGFR cystatin C with PDAY score were modest and similar in children [-0.29 (p = 0.008) vs. -0.32 (p = 0.004), respectively]. Despite a smaller sample size, the correlation in adults was stronger for eGFR cystatin C (-0.57; p = 0.006) than for eGFR creatinine (-0.40; p = 0.07). CONCLUSIONS: Overall, the correlation between cystatin C- or creatinine-based eGFR with PDAY risk score was similar in children. Further studies in children with CKD should explore the association between cystatin C and cardiovascular risk.
BACKGROUND:Children with chronic kidney disease (CKD) have a high prevalence of cardiovascular disease (CVD) risk factors which may contribute to the development of cardiovascular events in adulthood. Among adults with CKD, cystatin C-based estimates of glomerular filtration rate (eGFR) demonstrate a stronger predictive value for cardiovascular events than creatinine-based eGFR. The PDAY (Pathobiological Determinants of Atherosclerosis in Youth) risk score is a validated tool used to estimate the probability of advanced coronary atherosclerotic lesions in young adults. OBJECTIVE: To assess the association between cystatin C-based versus creatinine-based eGFR (eGFR cystatin C and eGFR creatinine, respectively) and cardiovascular risk using a modified PDAY risk score as a proxy for CVD in children and young adults. METHODS: We performed a cross-sectional study of 71 participants with CKD [median age 15.5 years; inter-quartile range (IQR) 13, 17], and 33 healthy controls (median age 15.1 years; IQR 13, 17). eGFR was calculated using age-appropriate creatinine- and cystatin C-based formulas. Median eGFR creatinine and eGFR cystatin C for CKD participants were 50 (IQR 30, 75) and 53 (32, 74) mL/min/1.73 m2, respectively. For the healthy controls, median eGFR creatinine and eGFR cystatin were 112 (IQR 85, 128) and 106 mL/min/1.73m2 (95, 123) mL/min/1.73 m2, respectively. A modified PDAY risk score was calculated based on sex, age, serum lipoprotein concentrations, obesity, smoking status, hypertension, and hyperglycemia. RESULTS: Modified PDAY scores ranged from -2 to 20. The Spearman's correlations of eGFR creatinine and eGFR cystatin C with coronary artery PDAY scores were -0.23 (p = 0.02) and -0.28 (p = 0.004), respectively. Ordinal logistic regression also showed a similar association of higher eGFR creatinine and higher eGFR cystatin C with lower PDAY scores. When stratified by age <18 or ≥18 years, the correlations of eGFR creatinine and eGFR cystatin C with PDAY score were modest and similar in children [-0.29 (p = 0.008) vs. -0.32 (p = 0.004), respectively]. Despite a smaller sample size, the correlation in adults was stronger for eGFR cystatin C (-0.57; p = 0.006) than for eGFR creatinine (-0.40; p = 0.07). CONCLUSIONS: Overall, the correlation between cystatin C- or creatinine-based eGFR with PDAY risk score was similar in children. Further studies in children with CKD should explore the association between cystatin C and cardiovascular risk.
Entities:
Keywords:
Cardiovascular disease; Cardiovascular risk; Chronic kidney disease; PDAY; Pathobiological Determinants of Atherosclerosis in Youth
Authors: Nisha Bansal; Eric Vittinghoff; Carmen A Peralta; Michael G Shlipak; Vanessa Grubbs; David R Jacobs; David Siscovick; Michael Steffes; John Jeffrey Carr; Kirsten Bibbins-Domingo Journal: Am J Epidemiol Date: 2013-06-27 Impact factor: 4.897
Authors: Amy C Wilson; Michael F Schneider; Christopher Cox; Larry A Greenbaum; Jeffrey Saland; Colin T White; Susan Furth; Bradley A Warady; Mark M Mitsnefes Journal: Clin J Am Soc Nephrol Date: 2011-10-06 Impact factor: 8.237
Authors: C Alex McMahan; Samuel S Gidding; Zahi A Fayad; Arthur W Zieske; Gray T Malcom; Richard E Tracy; Jack P Strong; Henry C McGill Journal: Arch Intern Med Date: 2005-04-25
Authors: P Svensson-Färbom; M Ohlson Andersson; P Almgren; B Hedblad; G Engström; M Persson; A Christensson; O Melander Journal: J Intern Med Date: 2013-12-20 Impact factor: 8.989
Authors: Erum A Hartung; Nina Laney; Ji Young Kim; Rebecca L Ruebner; John A Detre; Hua-Shan Liu; Christos Davatzikos; Guray Erus; Jimit J Doshi; Robert T Schultz; John D Herrington; Abbas F Jawad; Divya G Moodalbail; Ruben C Gur; Allison M Port; Jerilynn Radcliffe; Stephen R Hooper; Susan L Furth Journal: BMC Nephrol Date: 2015-04-30 Impact factor: 2.388